LINKBANCORP, Inc. (NASDAQ:LNKB – Get Free Report) declared a quarterly dividend on Thursday, January 23rd, Wall Street Journal reports. Investors of record on Friday, February 28th will be given a dividend of 0.075 per share on Friday, March 14th. This represents a $0.30 dividend on an annualized basis and a dividend yield of 4.00%. The ex-dividend date is Friday, February 28th.
LINKBANCORP has increased its dividend payment by an average of 58.7% per year over the last three years. LINKBANCORP has a dividend payout ratio of 31.9% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect LINKBANCORP to earn $0.94 per share next year, which means the company should continue to be able to cover its $0.30 annual dividend with an expected future payout ratio of 31.9%.
LINKBANCORP Price Performance
Shares of LNKB opened at $7.50 on Wednesday. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.00 and a quick ratio of 1.00. LINKBANCORP has a 1-year low of $5.86 and a 1-year high of $7.98. The stock has a market cap of $280.28 million, a PE ratio of 10.71 and a beta of 0.44. The firm has a fifty day moving average price of $7.37 and a 200 day moving average price of $6.98.
Wall Street Analysts Forecast Growth
Separately, DA Davidson reissued a “buy” rating and issued a $9.00 price objective on shares of LINKBANCORP in a report on Thursday, January 30th.
Get Our Latest Research Report on LINKBANCORP
About LINKBANCORP
LINKBANCORP, Inc operates as a bank holding company for The Gratz Bank, that provides various banking products and services to individuals, families, nonprofit, and business customers in Pennsylvania. Its deposit products include demand, saving, and money market accounts, as well as certificates of deposits.
See Also
- Five stocks we like better than LINKBANCORP
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Etsy Loses Its Meme Stock Shine – Is It Still a Buy?
- 3 Healthcare Dividend Stocks to Buy
- Stanley Druckenmiller Bets Big on Airline Stocks – Should You?
- What is the Nasdaq? Complete Overview with History
- Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?
Receive News & Ratings for LINKBANCORP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LINKBANCORP and related companies with MarketBeat.com's FREE daily email newsletter.